View monthly record counts
| Month | Records |
|---|---|
| 3 | |
| 10 | |
| 13 | |
| 8 |
Data updated:
| Month | Records |
|---|---|
| 3 | |
| 10 | |
| 13 | |
| 8 |
| # | Country / Region | Records |
|---|---|---|
| 1 | Singapore | 22 |
| # | HS Code | Description (CN) | Description (EN) | Records |
|---|---|---|---|---|
| 1 | 210690 | 未列名食品 | Food preparations, n.e.s. | 19 |
| 2 | 300490 | 其他混合或非混合产品构成的药品,已配定剂量或制成零售包装 | Other Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, in forms or packings for retail sale | 10 |
| 3 | 300410 | 含有青霉素和链霉素及其衍生物的药品,已配定剂量或制成零售包装 | Medicaments containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivatives,in forms or packings for retail sale | 4 |
| # | Partner Name | Country / Region | Records |
|---|---|---|---|
| 1 | ALLIANCE PHARM PTE LTD | SINGAPORE | 21 |
| 2 | IMMUNUS CLINIC NIHONBASHI | — | 2 |
| 3 | ORII CLINIC | — | 2 |
| Date | Feb 06, 2026 | Bill No. | — | ||
|---|---|---|---|---|---|
| Supplier Information | Company Name | TP PHARMACY SDN BHD | Buyer Information | Company Name | ALLIANCE PHARM PTE LTD |
| Address | NO. 28, JLN ASTANA 1D/KU2, | Address | — | ||
| Registration No. | 46067A | Registration No. | — | ||
| Phone | — | Phone | — | ||
| — | — | ||||
| Product Information | HS Code | 30049099 | HS Description | 其他混合或非混合产品构成的药品,已配定剂量或制成零售包装Other Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, in forms or packings for retail sale | |
| Product Description | ALPHAGAN P 0.1% OPTHALMIC SOLUTION | Brand | — | ||
| Quantity & Price | Amount | 2,295.10 | Weight | 107 kg | |
| Quantity | 107 KGM | TEU | — | ||
| Shipment Information | Origin Country | MALAYSIA | Destination Country | SINGAPORE | |
| Port of Loading | SINGAPORE | Destination Port | KULMY | ||
| Loading Place | — | Transport Mode | AIR | ||
| Transaction Mode | — | Carrier | — | ||
| Vessel Name | — | Voyage | — | ||
| Container No. | H818082112 | Shipping Country | — | ||